Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

United States Over The Counter (OTC) Drugs Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The United States over the counter (OTC) drugs market is expected to exhibit a CAGR of 5.40% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Over-the-counter (OTC) drugs are medicines that can be used without the requirement of a prescription signed by a healthcare professional. They help treat or prevent common health problems, such as allergies, constipation, cold and flu, nausea, musculoskeletal pain, headaches, heartburn, dermatitis, obesity, and dental caries. They are convenient, cheaper, and widely available at groceries, big box stores and pharmacies compared to prescribed drugs. At present, there is a rise in the demand for OTC drugs in the United States due to a shift towards self-medication for minor health problems among individuals.

United States Over The Counter (OTC) Drugs Market Trends:

The growing adoption of OTC drugs due to their cost-effectiveness represents one of the key factors driving the market in the US. Moreover, rising encouragement for the use of OTC drugs by the US Government, along with the wide availability of these drugs through online and offline channels, is propelling the growth of the market. In addition, there is an increase in the demand for private-label OTC drugs that enable manufacturers to have a guaranteed revenue stream. This, coupled with the growing mergers and acquisitions (M&A) between private label OTC manufacturers and e-commerce companies, is positively influencing the market. Besides this, key market players operating in the country are investing in research and development (R&D) activities to introduce new OTC drugs for various health conditions. In line with this, the rising number of retail stores offering OTC products is offering lucrative growth opportunities to industry investors. Additionally, the increasing utilization of VMS (vitamins, minerals, and supplements) and weight-loss OTC drugs among the masses is bolstering the growth of the market in the country.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the United States over the counter (OTC) drugs market, along with forecasts at the country and regional level from 2022-2027. Our report has categorized the market based on product type, route of administration, dosage form and distribution channel.

Breakup by Product Type:

  • Cough, Cold and Flu Products
  • Analgesics
  • Dermatology Products
  • Gastrointestinal Products
  • Vitamins, Minerals and Supplements (VMS)
  • Weight-loss/Dietary Products
  • Ophthalmic Products
  • Sleeping Aids
  • Others
     

Breakup by Route of Administration:

  • Oral
  • Parenteral
  • Topical
  • Others
     

Breakup by Dosage Form:

  • Tablets and Capsules
  • Liquids
  • Ointments
  • Others
     

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others
     

Breakup by Region:

  • Northeast
  • Midwest
  • South
  • West
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
    Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Product Type, Route of Administration, Dosage Form, Distribution Channel, Region
Region Covered Northeast, Midwest, South, West
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2699
Five User License: US$ 3699
Corporate License: US$ 4699
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

1    Preface
2    Scope and Methodology 

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    United States Over The Counter (OTC) Drugs Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Product Type
    6.1    Cough, Cold and Flu Products
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Analgesics
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Dermatology Products
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Gastrointestinal Products
        6.4.1 Market Trends
        6.4.2 Market Forecast
    6.5    Vitamins, Minerals and Supplements (VMS)
        6.5.1 Market Trends
        6.5.2 Market Forecast
    6.6    Weight-loss/Dietary Products
        6.6.1 Market Trends
        6.6.2 Market Forecast
    6.7    Ophthalmic Products
        6.7.1 Market Trends
        6.7.2 Market Forecast
    6.8    Sleeping Aids
        6.8.1 Market Trends
        6.8.2 Market Forecast
    6.9    Others
        6.9.1 Market Trends
        6.9.2 Market Forecast
7    Market Breakup by Route of Administration
    7.1    Oral
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Parenteral
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Topical
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Others
        7.4.1 Market Trends
        7.4.2 Market Forecast
8    Market Breakup by Dosage Form
    8.1    Tablets and Capsules
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Liquids
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Ointments
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Others
        8.4.1 Market Trends
        8.4.2 Market Forecast
9    Market Breakup by Distribution Channel
    9.1    Hospital Pharmacies
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Retail Pharmacies
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Online Pharmacies
        9.3.1 Market Trends
        9.3.2 Market Forecast
    9.4    Others
        9.4.1 Market Trends
        9.4.2 Market Forecast 
10    Market Breakup by Region
    10.1    Northeast
        10.1.1 Market Trends
        10.1.2 Market Forecast
    10.2    Midwest
        10.2.1 Market Trends
        10.2.2 Market Forecast
    10.3    South
        10.3.1 Market Trends
        10.3.2 Market Forecast
    10.4    West
        10.4.1 Market Trends
        10.4.2 Market Forecast
11    SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12    Value Chain Analysis
13    Porters Five Forces Analysis

    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14    Price Analysis
15    Policy and Regulatory Landscape
16    Competitive Landscape

    16.1    Market Structure
    16.2    Key Players
    16.3    Profiles of Key Players

List of Figures

Figure 1: United States: Over The Counter Drugs Market: Major Drivers and Challenges
Figure 2: United States: Over The Counter Drugs Market: Sales Value (in Billion US$), 2016-2021
Figure 3: United States: Over The Counter Drugs Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: United States: Over The Counter Drugs Market: Breakup by Product Type (in %), 2021
Figure 5: United States: Over The Counter Drugs Market: Breakup by Route of Administration (in %), 2021
Figure 6: United States: Over The Counter Drugs Market: Breakup by Dosage Form (in %), 2021
Figure 7: United States: Over The Counter Drugs Market: Breakup by Distribution Channel (in %), 2021
Figure 8: United States: Over The Counter Drugs Market: Breakup by Region (in %), 2021
Figure 9: United States: Over The Counter Drugs (Cough, Cold and Flu Products) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: United States: Over The Counter Drugs (Cough, Cold and Flu Products) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: United States: Over The Counter Drugs (Analgesics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: United States: Over The Counter Drugs (Analgesics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: United States: Over The Counter Drugs (Dermatology Products) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: United States: Over The Counter Drugs (Dermatology Products) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: United States: Over The Counter Drugs (Gastrointestinal Products) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: United States: Over The Counter Drugs (Gastrointestinal Products) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: United States: Over The Counter Drugs (Vitamins, Minerals and Supplements (VMS)) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: United States: Over The Counter Drugs (Vitamins, Minerals and Supplements (VMS)) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: United States: Over The Counter Drugs (Weight-loss/Dietary Products) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: United States: Over The Counter Drugs (Weight-loss/Dietary Products) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: United States: Over The Counter Drugs (Ophthalmic Products) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: United States: Over The Counter Drugs (Ophthalmic Products) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: United States: Over The Counter Drugs (Sleeping Aids) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: United States: Over The Counter Drugs (Sleeping Aids) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: United States: Over The Counter Drugs (Other Product Types) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: United States: Over The Counter Drugs (Other Product Types) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: United States: Over The Counter Drugs (Oral) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: United States: Over The Counter Drugs (Oral) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: United States: Over The Counter Drugs (Parenteral) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: United States: Over The Counter Drugs (Parenteral) Market Forecast: Sales Value (in Million US$) 2022-2027
Figure 31: United States: Over The Counter Drugs (Topical) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: United States: Over The Counter Drugs (Topical) Market Forecast: Sales Value (in Million US$) 2022-2027
Figure 33: United States: Over The Counter Drugs (Other Route of Administrations) Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: United States: Over The Counter Drugs (Other Route of Administrations) Market Forecast: Sales Value (in Million US$) 2022-2027
Figure 35: United States: Over The Counter Drugs (Tablets and Capsules) Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: United States: Over The Counter Drugs (Tablets and Capsules) Market Forecast: Sales Value (in Million US$) 2022-2027
Figure 37: United States: Over The Counter Drugs (Liquids) Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: United States: Over The Counter Drugs (Liquids) Market Forecast: Sales Value (in Million US$) 2022-2027
Figure 39: United States: Over The Counter Drugs (Ointments) Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: United States: Over The Counter Drugs (Ointments) Market Forecast: Sales Value (in Million US$) 2022-2027
Figure 41: United States: Over The Counter Drugs (Other Dosage Forms) Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: United States: Over The Counter Drugs (Other Dosage Forms) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: United States: Over The Counter Drugs (Hospital Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: United States: Over The Counter Drugs (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: United States: Over The Counter Drugs (Retail Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: United States: Over The Counter Drugs (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: United States: Over The Counter Drugs (Online Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: United States: Over The Counter Drugs (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: United States: Over The Counter Drugs (Other Distribution Channels) Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: United States: Over The Counter Drugs (Other Distribution Channels) Market Forecast: Sales Value (in Million US$) 2022-2027
Figure 51: Northeast: Over The Counter Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: Northeast: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Midwest: Over The Counter Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Midwest: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: South: Over The Counter Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: South: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: West: Over The Counter Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: West: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: United States: Over The Counter Drugs Industry: SWOT Analysis
Figure 60: United States: Over The Counter Drugs Industry: Value Chain Analysis
Figure 61: United States: Over The Counter Drugs Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: United States: Over The Counter Drugs Market: Key Industry Highlights, 2021 and 2027
Table 2: United States: Over The Counter Drugs Market Forecast: Breakup by Product Type (in Million US$), 2022-2027
Table 3: United States: Over The Counter Drugs Market Forecast: Breakup by Route of Administration (in Million US$), 2022-2027
Table 4: United States: Over The Counter Drugs Market Forecast: Breakup by Dosage Form (in Million US$), 2022-2027
Table 5: United States: Over The Counter Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2022-2027
Table 6: United States: Over The Counter Drugs Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 7: United States: Over The Counter Drugs Market: Competitive Structure
Table 8: United States: Over The Counter Drugs Market: Key Players


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Key Questions Answered in This Report

We expect the United States over the counter (OTC) drugs market to exhibit a CAGR of 5.40% during 2022-2027.

The increasing adoption of OTC drugs to treat minor ailments, along with the growing demand for nutritional supplements, owing to the emerging trend of self-care, is primarily driving the United States over the counter (OTC) drugs market.

The sudden outbreak of the COVID-19 pandemic has led to the rising inclination towards OTC drugs, including antibiotics, multi-vitamin tablets, cough syrups, etc., for treating the mild symptoms of the coronavirus infection across the nation.

 

Based on the product type, the United States over the counter (OTC) drugs market has been divided into cough, cold and flu products, analgesics, dermatology products, gastrointestinal products, Vitamins, Minerals and Supplements (VMS), weight-loss/dietary products, ophthalmic products, sleeping aids, and others. Among these, Vitamins, Minerals and Supplements (VMS) currently exhibit a clear dominance in the market.

Based on the route of administration, the United States over the counter (OTC) drugs market can be categorized into oral, parenteral, topical, and others. Currently, oral holds the majority of the total market share.

Based on the dosage form, the United States over the counter (OTC) drugs market has been segregated into tablets and capsules, liquids, ointments, and others, where tablets and capsules currently account for the largest market share.

 

Based on the distribution channel, the United States over the counter (OTC) drugs market can be bifurcated into hospital pharmacies, retail pharmacies, online pharmacies, and others. Currently, retail pharmacies hold the majority of the total market share.

On a regional level, the market has been classified into Northeast, Midwest, South, and West, where West currently dominates the United States over the counter (OTC) market.

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2699

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links

4